178 related articles for article (PubMed ID: 34450329)
21. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
22. The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits.
Kajiwara Y; McKenzie A; Dorr N; Gama Sosa MA; Elder G; Schmeidler J; Dickstein DL; Bozdagi O; Zhang B; Buxbaum JD
Hum Mol Genet; 2016 Oct; 25(19):4315-4327. PubMed ID: 27516385
[TBL] [Abstract][Full Text] [Related]
23. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
24. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
25. Low brain ascorbic acid increases susceptibility to seizures in mouse models of decreased brain ascorbic acid transport and Alzheimer's disease.
Warner TA; Kang JQ; Kennard JA; Harrison FE
Epilepsy Res; 2015 Feb; 110():20-5. PubMed ID: 25616451
[TBL] [Abstract][Full Text] [Related]
26. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
[TBL] [Abstract][Full Text] [Related]
27. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
Bernardo A; Harrison FE; McCord M; Zhao J; Bruchey A; Davies SS; Jackson Roberts L; Mathews PM; Matsuoka Y; Ariga T; Yu RK; Thompson R; McDonald MP
Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340
[TBL] [Abstract][Full Text] [Related]
28. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
[TBL] [Abstract][Full Text] [Related]
29. Intraperitoneal Administration of Monoclonal Antibody Against Pathologic Aβ42 Aggregates Alleviated Cognitive Deficits and Synaptic Lesions in APP/PS1 Mice.
Xiao S; Song LL; Li JT; Wang H; Yu N; Wang ZQ; Zhang Y; He JS; Hung T
J Alzheimers Dis; 2020; 73(2):657-670. PubMed ID: 31839610
[TBL] [Abstract][Full Text] [Related]
30. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
[TBL] [Abstract][Full Text] [Related]
31. Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG Study.
Lopez S; Del Percio C; Forloni G; Frasca A; Drinkenburg WH; Lizio R; Noce G; Ferri R; Soricelli A; Stocchi F; Vacca L; Bordet R; Richardson JC; Babiloni C
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260655
[TBL] [Abstract][Full Text] [Related]
32. Ascorbate deficiency decreases dopamine release in gulo
Consoli DC; Brady LJ; Bowman AB; Calipari ES; Harrison FE
J Neurochem; 2021 May; 157(3):656-665. PubMed ID: 32797675
[TBL] [Abstract][Full Text] [Related]
33. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
[TBL] [Abstract][Full Text] [Related]
34. Isoflurane exposure during mid-adulthood attenuates age-related spatial memory impairment in APP/PS1 transgenic mice.
Su D; Zhao Y; Xu H; Wang B; Chen X; Chen J; Wang X
PLoS One; 2012; 7(11):e50172. PubMed ID: 23185565
[TBL] [Abstract][Full Text] [Related]
35. Differential proteomic and behavioral effects of long-term voluntary exercise in wild-type and APP-overexpressing transgenics.
Rao SK; Ross JM; Harrison FE; Bernardo A; Reiserer RS; Reiserer RS; Mobley JA; McDonald MP
Neurobiol Dis; 2015 Jun; 78():45-55. PubMed ID: 25818006
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice.
McClean PL; Jalewa J; Hölscher C
Behav Brain Res; 2015 Oct; 293():96-106. PubMed ID: 26205827
[TBL] [Abstract][Full Text] [Related]
37. Electroacupuncture Mitigates Hippocampal Cognitive Impairments by Reducing BACE1 Deposition and Activating PKA in APP/PS1 Double Transgenic Mice.
Tang Y; Shao S; Guo Y; Zhou Y; Cao J; Xu A; Wu J; Li Z; Xiang D
Neural Plast; 2019; 2019():2823679. PubMed ID: 31223308
[TBL] [Abstract][Full Text] [Related]
38. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
[TBL] [Abstract][Full Text] [Related]
39. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.
McClean PL; Parthsarathy V; Faivre E; Hölscher C
J Neurosci; 2011 Apr; 31(17):6587-94. PubMed ID: 21525299
[TBL] [Abstract][Full Text] [Related]
40. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
